Bio-Techne’s Advanced Cell Diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

Trump hikes tariffs on China by 10%

Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. President Donald Trump increased tariffs on imports

March 4, 2025

Exclusive: CMS study sabotages efforts to bolster nursing home staffing, advocates say

The Biden administration last year promised to establish minimum staffing levels for the nation’s roughly 15,000 nursing homes. It was the centerpiece of an agenda

August 29, 2023

M1 Kliniken AG also grows significantly in the first half of 2024 – Biotech Investments

EQS-News: M1 Kliniken AG / Key word(s): Half Year Results/Quarter Results Operating Profit (EBIT) almost doubled: M1 Kliniken AG also grows significantly in the first

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.